Six weeks after the injection, a significant reduction in liver metastasis was observed following RP11-417E7.1 knockdown, whereas THBS2 overexpression counteracted the inhibitory effect of shRP11-417E7.1 on tumor metastasis (Figs. 6G-H). This evidence concerns the gene THBS2 and neoplasm.